Archive · 22 Dec 2025
IIT Madras Develops Nano Injection for Precise Breast Cancer Drug Delivery
Scientists from IIT Madras and Australian universities have created a tiny, precise way to deliver medicine directly to breast cancer cells.
This new method uses special tiny tubes made of silicon to carry the drug doxorubicin right into the cancer cells.
This helps to kill the cancer cells more effectively while causing less harm to healthy cells.
The new system is also cheaper and has fewer side effects compared to traditional treatments.
The researchers tested it on cancer cells and chick embryos, and it worked really well.
They hope this new technology can make cancer treatment better and more affordable, especially in countries like India.
The next step is to test it in animals and make sure it's safe for people.
IIT Madras and Australian universities developed a nanoinjection platform for precise breast cancer drug delivery.
The system uses silicon nanotubes to deliver doxorubicin directly to cancer cells, minimizing damage to healthy cells.
Experiments showed the platform is 23 times more potent than free doxorubicin, reducing treatment costs and side effects.
The technology is biocompatible and non-toxic, making it scalable for future clinical use.
Next steps include in vivo validation, long-term toxicity studies, and regulatory assessments for clinical translation.
- Who
- Researchers from IIT Madras, Monash University, and Deakin University
- What
- Developed a nanoinjection drug delivery platform for breast cancer treatment
- When
- Not specified
- Where
- India and Australia
- Why
- To make breast cancer treatment safer, more effective, and affordable
- Research Team
- IIT Madras, Monash University, Deakin University
- Drug Delivery System
- Nanoarchaeosome-Doxorubicin-Silicon nanotubes (NAD-SiNTs)
- Target Cancer Cells
- MCF-7 breast cancer cells
- Efficacy
- 23 times lower inhibitory concentration (IC50) than free doxorubicin
- Potential Impact
- Lower treatment costs, fewer side effects, and improved quality of life
- Next Steps
- In vivo validation, long-term toxicity studies, and regulatory assessments
- Publication
- Advanced Materials Interfaces
